Immunopeptidomics for Precision Therapies

Understanding and targeting the immunopeptidome is often critical for advancing immuno-oncology and autoimmune therapies, but researchers commonly encounter challenges related to sensitivity, reproducibility, and limited sample availability. Biognosys’ advanced immunopeptidome profiling services and tailored bioinformatics enable precise identification and quantification of MHC-presented peptides in human and pre-clinical species using minimal sample input. With extensive experience in TCR-T therapies, cancer vaccines, and immunomodulatory treatments, Biognosys is your trusted partner in driving innovation in precision therapies.

Download Flyer